{"altmetric_id":20732045,"counts":{"readers":{"mendeley":0,"citeulike":1,"connotea":0},"total":{"posts_count":1},"wikipedia":{"unique_users_count":1,"unique_users":["en:50631740"],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa4e93cf058f6100023f1","authors":["Manish Malviya","Y.C. Sunil Kumar","D. Asha","J.N. Narendra Sharath Chandra","M.N. Subhash","K.S. Rangappa"],"doi":"10.1016\/j.bmc.2008.06.053","first_seen_on":"2017-05-31T15:51:08+00:00","issns":["09680896"],"issue":"15","journal":"Bioorganic & Medicinal Chemistry","last_mentioned_on":1496245865,"links":["http:\/\/dx.doi.org\/10.1016\/j.bmc.2008.06.053"],"pmid":"18640043","pubdate":"2008-08-01T00:00:00+00:00","publisher_subjects":[{"name":"Medicinal And Biomolecular Chemistry","scheme":"era"},{"name":"Pharmacology And Pharmaceutical Sciences","scheme":"era"},{"name":"Organic Chemistry","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"subjects":["chemistry","biochemistry"],"title":"Muscarinic receptor 1 agonist activity of novel N-arylthioureas substituted 3-morpholino arecoline derivatives in Alzheimer\u2019s presenile dementia models","type":"article","volume":"16","mendeley_url":"http:\/\/www.mendeley.com\/research\/muscarinic-receptor-1-agonist-activity-novel-naryl-carboxamide-substituted-3morpholino-arecoline-der"},"altmetric_score":{"score":3,"score_history":{"1y":3,"6m":3,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":8296164,"mean":6.9911317525872,"rank":2119120,"this_scored_higher_than_pct":60,"this_scored_higher_than":5045754,"rank_type":"exact","sample_size":8296164,"percentile":60},"similar_age_3m":{"total_number_of_other_articles":240199,"mean":12.039170917326,"rank":79165,"this_scored_higher_than_pct":66,"this_scored_higher_than":158586,"rank_type":"exact","sample_size":240199,"percentile":66},"this_journal":{"total_number_of_other_articles":1354,"mean":2.3985705838877,"rank":193,"this_scored_higher_than_pct":65,"this_scored_higher_than":893,"rank_type":"exact","sample_size":1354,"percentile":65},"similar_age_this_journal_3m":{"total_number_of_other_articles":56,"mean":1.4423636363636,"rank":7,"this_scored_higher_than_pct":87,"this_scored_higher_than":49,"rank_type":"exact","sample_size":56,"percentile":87}}},"demographics":{"users":{"mendeley":{"by_status":{"Unspecified":1,"Researcher":3,"Student  > Doctoral Student":1,"Student  > Ph. D. Student":3,"Student  > Master":1,"Other":3},"by_discipline":{"Medicine and Dentistry":1,"Neuroscience":1,"Chemistry":3,"Agricultural and Biological Sciences":3,"Biochemistry, Genetics and Molecular Biology":2,"Unspecified":1,"Pharmacology, Toxicology and Pharmaceutical Science":1}}},"geo":{"mendeley":{"BR":1,"IN":1}}},"posts":{"wikipedia":[{"title":"ANAVEX2-73","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=783174605#altmetric_citation_4fc3f6c0-2c66-4789-9fe2-2d49ec6ee4c6","license":"public","citation_ids":[20732045],"posted_on":"2017-05-31T15:51:05+00:00","summary":"ANAVEX2-73 is derived from aminotetrahydrofuran. This drug is in Phase II trials for Alzheimer's disease, phase I trials for epilepsy, and in preclinical trials for amyotrophic lateral sclerosis, Parkinson's disease, Rett syndrome, stroke.","page_url":"http:\/\/en.wikipedia.org\/?curid=50631740","wiki_lang":"en","author":{"name":"Rjwilmsi","url":"http:\/\/en.wikipedia.org\/wiki\/User:Rjwilmsi"}}]}}